Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
$9.75
+2.6%		$8.05
$4.50
▼
$10.10
$212.34M2.31123,964 shs294,247 shs
IBO
Impact Biomedical
$0.48
+6.8%		$0.46
$0.37
▼
$0.83
$51.75M2.7331,333 shs21,655 shs
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
$4.54
+0.4%		$4.84
$3.63
▼
$8.98
$171.85M1.08135,647 shs90,552 shs
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
$0.16
-32.9%		$0.20
$0.01
▼
$0.04
$124.78M2.71.75 million shs414 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
0.00%+10.29%+18.47%+66.67%+22.03%
IBO
Impact Biomedical
0.00%+4.51%+11.55%-11.73%-18.63%
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
0.00%-3.81%+2.48%-7.91%-37.29%
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
-32.89%-26.82%-23.33%-34.02%-76.18%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
$9.75
+2.6%		$8.05
$4.50
▼
$10.10
$212.34M2.31123,964 shs294,247 shs
IBO
Impact Biomedical
$0.48
+6.8%		$0.46
$0.37
▼
$0.83
$51.75M2.7331,333 shs21,655 shs
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
$4.54
+0.4%		$4.84
$3.63
▼
$8.98
$171.85M1.08135,647 shs90,552 shs
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
$0.16
-32.9%		$0.20
$0.01
▼
$0.04
$124.78M2.71.75 million shs414 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
0.00%+10.29%+18.47%+66.67%+22.03%
IBO
Impact Biomedical
0.00%+4.51%+11.55%-11.73%-18.63%
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
0.00%-3.81%+2.48%-7.91%-37.29%
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
-32.89%-26.82%-23.33%-34.02%-76.18%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
3.00
Buy$18.0084.62% Upside
IBO
Impact Biomedical
0.00
N/AN/AN/A
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
2.00
Hold$6.5043.17% Upside
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest IBO, ACOG, UNRV, and LFCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/20/2026
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$21.00
8/19/2026
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
B. Riley Financial, Inc. logo
B. Riley Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$21.00
8/17/2026
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$18.00 ➝ $20.00
8/14/2026
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$17.00
8/4/2026
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/29/2026
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
7/10/2026
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$20.00
7/10/2026
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$20.00
6/30/2026
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
6/16/2026
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
Barrington Research logo
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$6.00 ➝ $6.50
5/29/2026
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
Maxim Group logo
Maxim Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$12.00
(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
$10.22M20.78N/AN/A$2.43 per share4.01
IBO
Impact Biomedical
$30K1,725.12N/AN/A$0.13 per share3.69
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
$128.87M1.33N/AN/A($0.90) per share-5.04
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
$52.01M2.40N/AN/A($0.06) per share-2.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
-$20.67M-$1.10N/AN/AN/A-153.61%-54.60%-43.47%N/A
IBO
Impact Biomedical
-$11.84MN/AN/AN/AN/A2,254.28%8.81%4.49%N/A
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
N/A-$1.07N/AN/AN/A-29.93%N/A-16.16%10/2/2026 (Estimated)
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
-$188.93M$0.0116.12N/AN/A-2.37%N/A-1.16%N/A

Latest IBO, ACOG, UNRV, and LFCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
-$0.3921-$0.40-$0.0079-$0.40$4.38 million$6.00 million
8/5/2026Q2 2026
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
-$0.19-$0.19N/A-$0.19$34.18 million$34.17 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
N/AN/AN/AN/AN/A
IBO
Impact Biomedical
N/AN/AN/AN/AN/A
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
N/AN/AN/AN/AN/A
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
N/A
9.03
8.04
IBO
Impact Biomedical
N/A
0.16
0.13
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
N/A
3.87
2.69
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
N/A
0.12
0.08

Institutional Ownership

CompanyInstitutional Ownership
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
N/A
IBO
Impact Biomedical
N/A
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
83.36%
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
N/A

Insider Ownership

CompanyInsider Ownership
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
8.60%
IBO
Impact Biomedical
89.00%
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
32.68%
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
17.18%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
N/A21.78 million19.91 millionN/A
IBO
Impact Biomedical
N/A107.82 million11.86 millionN/A
Lifecore Biomedical, Inc. stock logo
LFCR
Lifecore Biomedical
69037.85 million25.48 millionOptionable
Unrivaled Brands, Inc. stock logo
UNRV
Unrivaled Brands
330775.00 million641.85 millionNot Optionable

Recent News About These Companies

Unrivaled’s Spirits Sponsorship Reflects New Reality In Women’s Sports
February 27, 2026  |  forbes.comhttps://www.forbes.com/sites/roberta-rodrigues/2026/02/27/unrivaleds-spirits-sponsorship-reflects-new-reality-in-womens-sports/
Sephora secures naming rights at Unrivaled’s Miami arena
December 4, 2025  |  sportsbusinessjournal.comS
Unrivaled Expands With Two New Clubs Ahead Of Second Season
September 10, 2025  |  msn.comhttps://www.msn.com/en-us/sports/basketball/unrivaled-expands-with-two-new-clubs-ahead-of-second-season/ar-AA1MiS3J
Unrivaled Announces Breeze BC, Hive BC as New Teams for 2026 Season in Video
September 10, 2025  |  bleacherreport.comB
Unrivaled announces two expansion teams for Year 2 with stars like Paige Bueckers set to join league
September 10, 2025  |  msn.comhttps://www.msn.com/en-us/sports/other/unrivaled-announces-two-expansion-teams-for-year-2-with-stars-like-paige-bueckers-set-to-join-league/ar-AA1MiXMd
Serena Williams Invests in Unrivaled Women's Basketball League, Valued at $340M
September 9, 2025  |  msn.comhttps://www.msn.com/en-us/sports/basketball/serena-williams-invests-in-unrivaled-women-s-basketball-league-valued-at-340m/ar-AA1M8EMM
'The Future Is Unrivaled': League Expands NIL Roster And Drops Bold New Merchandise Line
September 3, 2025  |  msn.comhttps://www.msn.com/en-us/sports/basketball/the-future-is-unrivaled-league-expands-nil-roster-and-drops-bold-new-merchandise-line/ar-AA1LOwRL
Michael Jordan’s $7 Billion Brand Signs Unrivaled Founder and WNBA DPOY Napheesa Collier
May 17, 2025  |  msn.comhttps://www.msn.com/en-us/sports/other/michael-jordan-s-7-billion-brand-signs-unrivaled-founder-and-wnba-dpoy-napheesa-collier/ar-AA1EXtRr
How Unrivaled built brand partnerships that are more than logo slaps
May 12, 2025  |  marketingdive.comM
Dick’s Sporting Leads $120 Million Funding Round for Unrivaled
May 6, 2025  |  msn.comhttps://www.msn.com/en-us/money/other/dick-s-sporting-leads-120-million-funding-round-for-unrivaled/ar-AA1EgHlY
What's next for Unrivaled? Year 2 will include visits to other markets, more players
March 18, 2025  |  msn.comhttps://www.msn.com/en-us/sports/other/whats-next-for-unrivaled-year-2-will-include-visits-to-other-markets-more-players/ar-AA1B6D1n
Here are four ways Unrivaled could change the WNBA
March 15, 2025  |  nytimes.comhttps://www.nytimes.com/athletic/6201969/2025/03/14/unrivaled-wnba-salary-change/
Q&A: Napheesa Collier on Unrivaled pushing personal brands, March Madness and more
March 15, 2025  |  msn.comhttps://www.msn.com/en-us/sports/nba/q-a-napheesa-collier-on-unrivaled-pushing-personal-brands-march-madness-and-more/ar-AA1AZjIt
Stephen Curry's Unrivaled investment is spectacularly on-brand
March 11, 2025  |  msn.comhttps://www.msn.com/en-us/sports/nba/stephen-currys-unrivaled-investment-is-spectacularly-on-brand/ar-AA1AH7Cd
Could The ‘Unrivaled’ 1v1 Tournament Influence The NBA?
March 2, 2025  |  msn.comhttps://www.msn.com/en-us/sports/basketball/could-the-unrivaled-1v1-tournament-influence-the-nba/ar-AA1A6KQS
Unrivaled’s Game-Changing Bet: How These WNBA Stars Are Reimagining the Business of Women’s Sports
February 18, 2025  |  inc.comhttps://www.inc.com/ximena-beltran-quan-kiu/unrivaleds-game-changing-bet-how-these-wnba-stars-are-reimagining-the-business-of-womens-sports/91147242
Unrivaled’s an instant hit, but can the new women’s basketball 3×3 league sustain?
January 21, 2025  |  nytimes.comhttps://www.nytimes.com/athletic/6076516/2025/01/21/unrivaled-womens-basketball-3on3-sustainability/
What Is Unrivaled, the New Women’s Basketball League That Has WNBA Fans Cheering?
January 17, 2025  |  vogue.comV
Unrivaled Opportunity: How Under Armour, Skechers and More Sneaker Brands Can Capitalize on the Women's Basketball Movement
January 17, 2025  |  msn.comhttps://www.msn.com/en-us/sports/basketball/unrivaled-opportunity-how-under-armour-skechers-and-more-sneaker-brands-can-capitalize-on-the-women-s-basketball-movement/ar-AA1xoLN3
Unrivaled, the new 3-on-3 women’s basketball league, set for debut
January 17, 2025  |  msn.comhttps://www.msn.com/en-us/sports/nba/unrivaled-the-new-3-on-3-womens-basketball-league-set-for-debut/ar-AA1xoeq5

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alpha Cognition stock logo

Alpha Cognition NASDAQ:ACOG

$9.75 +0.25 (+2.63%)
As of 08/21/2026 04:00 PM Eastern

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Impact Biomedical NYSEAMERICAN:IBO

$0.48 +0.03 (+6.83%)
As of 08/21/2026 04:10 PM Eastern

Impact Biomedical, Inc. (“IBIO”) currently is a holding company operating mainly through our majority owned subsidiary, Global BioLife, Inc., which was incorporated on April 14, 2017. The Company is committed to both funding research and developing intellectual property portfolio. We currently focus on research in three main areas: (i) development of a universal therapeutic drug platform; (ii) a new sugar substitute; and (iii) a multi-use fragrance. IBIO discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships. Currently, our operations are conducted, and our assets are owned through our principal subsidiaries: (i) Global BioLife, Inc. (“Global BioLife”), which was incorporated on April 14, 2017, (ii) Impact BioLife Science (“Impact BioLife”), which was incorporated on August 28, 2020, (iii) Global BioMedical, Inc. (“Global BioMedical”), which was incorporated on April 18, 2017, and (iv) Sweet Sense, Inc. (“Sweet Sense”), which was incorporated on April 30, 2018. By leveraging technology and new science with strategic partnerships, we provide advances in biopharmaceuticals and over the counter direct to consumer wellness offerings, and drug discovery for the prevention, inhibition, and treatment of neurological, oncology and immuno-related diseases. In addition to our existing efforts, we continually search for and evaluate other potential new offerings to add to our portfolio. Our business model includes partnering and potentially direct sales for commercialization and distribution. Potential licensors and development partners include pharmaceutical, consumer packaged goods companies and others, who would commercialize IBIO technologies in exchange for milestone, and royalty licensing payments. Below is a list of our principal subsidiaries: . Impact BioLife Science, Inc.; . Global Biomedical, Inc.; . Global BioLife, Inc.; and . Sweet Sense, Inc. Impact BioLife Science, Inc. We are the sole owner of the outstanding equity of Impact BioLife Science, Inc. Global Biomedical, Inc. We own 90.9% of Global Biomedical, Inc.’s outstanding equity. Global BioLife, Inc. Through our majority owned subsidiary Global Biomedical, Inc., we own 81.8% of the outstanding equity of Global BioLife, Inc. Sweet Sense, Inc. We are the owner of 95.5% of the outstanding equity of Sweet Sense. Impact BioMedical Inc. is a Nevada corporation and was incorporated in October 2018. Our principal executive offices are located at 1400 Broadfield Blvd., Suite 130, Houston, Texas.

Lifecore Biomedical stock logo

Lifecore Biomedical NASDAQ:LFCR

$4.54 +0.02 (+0.44%)
As of 08/21/2026 04:00 PM Eastern

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Unrivaled Brands stock logo

Unrivaled Brands OTCMKTS:UNRV

$0.16 -0.08 (-32.89%)
As of 08/21/2026

Unrivaled Brands, Inc. cultivates, produces, distributes, and retails medical and adult use cannabis products in California, Oregon, and Nevada. It also operates medical marijuana retail and adult use dispensaries, cultivation, and production facilities. The company was formerly known as Terra Tech Corp. and changed its name to Unrivaled Brands, Inc. in July 2021. Unrivaled Brands, Inc. was founded in 2010 and is based in Santa Ana, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas